endo.digital N/A

GUDID 07290017735023

endo.digital platform is a software device that is designed to provide insulin therapy adjustment recommendations to physicians to assist in the management of diabetes for patients with Type 1 diabetes using an insulin pump, a continuous glucose monitoring (CGM) system and self-management blood glucose meter (SMBG) and to patients with Type 2 diabetes on basal-bolus therapy via multiple daily injections (MDI), a continuous glucose monitoring (CGM) system and/or self-management blood glucose meter (SMBG). endo.digital gathers and analyses information inputted through the endo.digital Uploader or qualified Diabetes Management Systems (DMS), which collects biological input information from various diabetes devices. Diabetes device information required and used by endo.digital includes glucose readings (either CGM sensor readings and/or capillary blood glucose measurements), insulin dosing logs, and meal data during daily routine care. Following data collection and analysis, the endo.digital platform generates results containing summary data and recommendations for adjustments to the patient’s insulin therapy parameters, including a basal and bolus plan. endo.digital may also advise behavioral changes. The physician can approve, reject or change the recommendations and issue the updated treatment plan to the patients.

DREAMED DIABETES LTD

Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser Ambulatory insulin infusion pump remote control/blood glucose analyser

• Primary Device ID: 07290017735023
• NIH Device Record Key: 0aabefcf-ea49-44b8-a01b-ee497db06e07
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: endo.digital
• Version Model Number: 02.XX.YY
• Catalog Number: N/A
• Company DUNS: 600230110
• Company Name: DREAMED DIABETES LTD
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: false
• Device Combination Product: false
• Single Use: false
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: true
• Expiration Date: false
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: true
• OTC Over-The-Counter: false

Device Identifiers

Device Issuing Agency	Device ID
GS1	07290017735023 [Primary]

FDA Product Code

• OUG: Medical Device Data System

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: New
• Device Record Status: Published
• Public Version Number: 1
• Public Version Date: 2022-09-28
• Device Publish Date: 2022-09-20

Devices Manufactured by DREAMED DIABETES LTD

• 07290017735030 - Diary Mobile App: 2022-11-03 The Diary is a mobile app intended for use by people with diabetes, in order to log, track and share blood glucose levels, insul
• 07290017735023 - endo.digital: 2022-09-28endo.digital platform is a software device that is designed to provide insulin therapy adjustment recommendations to physicians to assist in the management of diabetes for patients with Type 1 diabetes using an insulin pump, a continuous glucose monitoring (CGM) system and self-management blood glucose meter (SMBG) and to patients with Type 2 diabetes on basal-bolus therapy via multiple daily injections (MDI), a continuous glucose monitoring (CGM) system and/or self-management blood glucose meter (SMBG). endo.digital gathers and analyses information inputted through the endo.digital Uploader or qualified Diabetes Management Systems (DMS), which collects biological input information from various diabetes devices. Diabetes device information required and used by endo.digital includes glucose readings (either CGM sensor readings and/or capillary blood glucose measurements), insulin dosing logs, and meal data during daily routine care. Following data collection and analysis, the endo.digital platform generates results containing summary data and recommendations for adjustments to the patient’s insulin therapy parameters, including a basal and bolus plan. endo.digital may also advise behavioral changes. The physician can approve, reject or change the recommendations and issue the updated treatment plan to the patients.
• 07290017735023 - endo.digital: 2022-09-28 endo.digital platform is a software device that is designed to provide insulin therapy adjustment recommendations to physicians
• 07290017735016 - DreaMed Advisor Pro: 2020-01-22 DreaMed Advisor Pro is a software product that is designed to provide advice on the control and management of diabetes for insul